Sickle cell disease patients showed significantly higher markers of endothelial function (TNF-α, IL-6, and IL-17A) in comparison to controls (p-values < 0.001, < 0.001, and 0.006, respectively) (Fig. 1). This evidence concerns the gene IL17A and sickle cell disease.